Core Laboratories N.V. provided earnings guidance for the third quarter of 2022. For the quarter, the company expected revenue to range from $123,000,000 to $129,000,000 and operating income of $10,100,000 to $13,300,000, yielding operating margins of approximately 9%. EPS for the third quarter of 2022 is expected to be $0.13 to $0.18.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.13 USD | -1.57% | +1.28% | +2.66% |
04-25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
04-24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.66% | 864M | |
+16.68% | 17.22B | |
-16.69% | 2.81B | |
-12.60% | 2.73B | |
-27.97% | 1.85B | |
-5.00% | 1.13B | |
-9.36% | 1.07B | |
-15.24% | 807M | |
-1.66% | 765M | |
-25.57% | 682M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories N.V. Provides Earnings Guidance for the Third Quarter of 2022